MorphoSys AG (MOR): Price and Financial Metrics

MorphoSys AG (MOR): $3.96

-0.16 (-3.88%)

POWR Rating

Component Grades













MOR Stock Price Chart Interactive Chart >

Price chart for MOR

MOR Price/Volume Stats

Current price $3.96 52-week high $7.45
Prev. close $4.12 52-week low $3.17
Day low $3.90 Volume 439,400
Day high $3.99 Avg. volume 144,865
50-day MA $4.46 Dividend yield N/A
200-day MA $4.70 Market Cap 542.23M

MorphoSys AG (MOR) Company Bio

MorphoSys AG engages in the research, development, and optimization of therapeutic antibody drug candidates in partnership with pharmaceutical and biotechnology companies. The company, together with its pharmaceutical partners, develops a therapeutic pipeline of approximately 100 drugs for the treatment of cancer, Alzheimer's disease, infectious diseases, cardiovascular dysfunction, and inflammation. The company was founded in 1992 and is based in Planegg, Germany.

MOR Latest News Stream

Event/Time News Detail
Loading, please wait...

MOR Latest Social Stream

Loading social stream, please wait...

View Full MOR Social Stream

Latest MOR News From Around the Web

Below are the latest news stories about MORPHOSYS AG that investors may wish to consider to help them evaluate MOR as an investment opportunity.

MorphoSys AG (NASDAQ:MOR) Q4 2022 Earnings Call Transcript

MorphoSys AG (NASDAQ:MOR) Q4 2022 Earnings Call Transcript March 16, 2023 Julia Neugebauer: Ladies and gentlemen, good afternoon and good morning. My name is Julia Neugebauer, Head of Investor Relations at MorphoSys, and it’s my pleasure to welcome you to our Fourth Quarter and Full Year 2022 Financial Results Conference Call. Joining me on the […]

Yahoo | March 20, 2023

MorphoSys Full Year 2022 Earnings: Beats Expectations

MorphoSys ( ETR:MOR ) Full Year 2022 Results Key Financial Results Revenue: €278.3m (up 55% from FY 2021). Net loss...

Yahoo | March 17, 2023

MorphoSys AG Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

PLANEGG/MUNICH, Germany, March 15, 2023--MorphoSys AG (FSE: MOR; NASDAQ: MOR) reports results for the fourth quarter and the full year 2022.

Yahoo | March 15, 2023

Invitation to MorphoSys' Full Year Results 2022 Conference Call on March 16, 2023

MorphoSys AG (FSE:MOR)(NASDAQ:MOR) will publish its results for the financial year 2022 on March 15, 2023 at 09:00 pm CET (08:00 pm GMT; 04:00 pm EDT).

Yahoo | March 9, 2023

MorphoSys Stops Work and Operations on Pre-Clinical Research Programs

MorphoSys AG (FSE:MOR)(NASDAQ:MOR) today announced that the company will stop work and operations on its pre-clinical research programs to optimize its cost structure. While the data from these pre-clinical programs are promising, MorphoSys would need to make substantial investments to bring these programs into the clinic. As a result, MorphoSys will reduce its workforce at the company's headquarters in Planegg, Germany, by approximately 17%.

Yahoo | March 2, 2023

Read More 'MOR' Stories Here

MOR Price Returns

1-mo -8.33%
3-mo 10.61%
6-mo -23.99%
1-year -43.43%
3-year -83.81%
5-year N/A
YTD 10.61%
2022 -62.00%
2021 -66.76%
2020 -20.55%
2019 40.99%
2018 N/A

Continue Researching MOR

Here are a few links from around the web to help you further your research on MorphoSys AG's stock as an investment opportunity:

MorphoSys AG (MOR) Stock Price | Nasdaq
MorphoSys AG (MOR) Stock Quote, History and News - Yahoo Finance
MorphoSys AG (MOR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7901 seconds.